Experiences of community pharmacists advising pregnant women

International Journal of Clinical Pharmacy

Volumn 37, Issue 4, 2015, Pages 636-644

  Grincevičienė, Švitrigailė ^a   Kubilienė, Loreta ^a   Ivanauskas, Kostas ^b   Drąsutienė, Gražina S ^b   Ramašauskaitė, Diana ^b   Grincevičius, Jonas ^a   Bernatonienė, Jurga ^a   Savickas, Arūnas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Advising pregnant women; Community pharmacy; Content analysis; Interviews; Lithuania; Pharmacy practice; Pregnancy

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INFORMATION DISSEMINATION; LITHUANIA; MALE; MEDICAL CARE; PHARMACIST; PHARMACIST ATTITUDE; PHYSICIAN PHARMACIST PATIENT COMMUNICATION; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SELF CARE; SEMI STRUCTURED INTERVIEW; AGED; HUMAN RELATION; INTERVIEW; MIDDLE AGED; PREGNANCY; PRENATAL CARE; PROCEDURES; PROFESSIONAL STANDARD; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; INTERVIEWS AS TOPIC; LITHUANIA; MALE; MIDDLE AGED; PHARMACISTS; PREGNANCY; PRENATAL CARE; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; YOUNG ADULT;

EID: 84937579235     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-015-0111-6     Document Type: Article

References (54)

1. Walsh RA. Effects of maternal smoking on adverse pregnancy outcomes: examination of the criteria of causation. Hum Biol. 1994;66(6):1059–92.
2. Chomitz VR, Cheung LW, Lieberman E. The role of lifestyle in preventing low birth weight. Future Child. 1995;5(1):121–38.
3. Bailey BA, Sokol RJ. Pregnancy and alcohol use: evidence and recommendations for prenatal care. Clin Obstet Gynecol. 2008;2(51):436–44.
4. Norman JE, Reynolds R. The consequences of obesity and excess weight gain in pregnancy. Proc Nutr Soc. 2011;4(70):450–6.
5. World Health Organization. Jakarta Declaration on Leading Health Promotion into the 21st Century [Internet]. Jakarta: World Health Organization. 1997. (cited 2014 Apr 18). http://www.alliance-healthycities.com/htmls/glossary/pdf/jakarta_declaration_en.pdf.
6. Bradley F, Ashcroft DM, Noyce PR. Integration and differentiation: a conceptual model of general practitioner and community pharmacist collaboration. Res Social Adm Pharm. 2012;8(1):36–461.
7. Boonyaprapa S. Self-care in pregnancy and breastfeeding: views of women and community pharmacists in Thailand. Dissertation. Nottingham: University of Nottingham. 2010.
8. Schrempp S, Ryan-Haddad A, Galt KA. Pharmacist counseling of pregnant or lactating women. J Am Pharm Assoc (Wash). 2001;41(6):887–90.
9. de Walle HEK, de Jong-van den Berg LT. Ten years after the Dutch public health campaign on folic acid: the continuing challenge. Eur J Clin Pharmacol. 2008;64(5):539–43.
10. Ballard P, Radley A. Give it up for baby—a smoking cessation intervention for pregnant women in Scotland (Internet). (Scotland): Cases Public Health Commun Mark. 2009;3:147–160 (cited 2014 Apr 18). www.casesjournal.org/volume3.
11. Le Durand M. rôle du pharmacien d’officine dans l’arrêt du tabac pendant la grossesse. J Gynecol Obstet Biol Reprod. 2005;34:336–8.
12. National Institute for Health and Clinical Excellence. Dietary interventions and physical activity interventions for weight management before, during and after pregnancy PH27 (Internet). London: National Institute for Health and Clinical Excellence. 2010 Jul (cited 2014 Apr 18). http://www.nice.org.uk/nicemedia/live/13056/49926/49926.pdf.
13. Shepherd AA. Nutrition through the life-span. Part 1: preconception, pregnancy and infancy. Br J Nurs. 2008;17(20):1261–8.
14. Hughes R, Maher J, Baillie E, Shelton D. Nutrition and physical activity guidance for women in the pre- and post-natal period: a continuing education needs assessment in primary health care. Aust J Prim Health. 2011;17(2):135–41.
15. Jaradat N, Sweileh W. Drug Information for community pharmacies: survey on needs and use of drug information with special focus on new information technology (Internet). (Nablus): an-Najah National University. 2003;17:287–300 (cited 2014 Apr 18). http://staff.najah.edu/sites/default/files/2003.1.Drug%20Information%20for%20Community%20Pharmacies%20Survey%20on%20Needs%20and%20Use%20of.pdf.
16. van Trigt AM, Waardenburg CM, Haaijer-Ruskamp FM, de Jong-van den Berg LT. Questions about drugs: How do pregnant women solve them? Pharm World Sci. 1994;16(6):254–9.
17. Pellerin P, Elefant E. Un rôle difficile pour le pharmacien d’officine, le conseil en matière de médicament et grossesse. Ann Pharm Fr. 2004;62(4):253–9.
18. Hämeen-Anttila K, Jyrkkä J, Enlund H, Nordeng H, Lupattelli A, Kokki E. Medicines information needs during pregnancy: a multinational comparison. BMJ Open 2013;3. doi:10.1136/bmjopen-2013-002594.
19. Nordeng H, Ystrom E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–14.
20. Law on Pharmacy in Lithuanian Republic. Pub L No. X-709, (Jun 22, 2006).
21. Order of Lithuanian Minister of Health No. V-494 Approval of good pharmacy practice guidances. www.lrs.lt.
22. Atkinson J, Rombaut B. The 2011 PHARMINE report on pharmacy and pharmacy education in the European Union. Pharm Pract (Granada). 2011;9(4):169–87.
23. Damase-Michel C, Vie C, Lacroix I. Drug counseling in pregnancy: an opinion survey of French community pharmacists. Pharmacoepidemiol Drug Saf. 2004;13(10):711–5.
24. Lyszkiewicz DA, Gerichhausen S, Björnsdóttir I, Einarson TR, Koren G, Einarson A. Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries. Pharm World Sci. 2001;23(2):76–81.
25. Anderson C, Rajyaguru R. The role of community pharmacists and medicines counter assistants in health promotion: reflections from a folic acid campaign. Int J Pharm Pract. 2002;1(10):17–22.
26. Hutschinson S, Mitchell K, Hansford D, Steward D. Community pharmacist’s views and experiences of counter-prescribing in pregnancy. Int J Pharm Pract. 2001;9:15–21.
27. Grincevičienė Š. The aspects of counseling of pregnant and breastfeeding women about healthy lifestyle and rational use of medications in Lithuanian pharmacies. Dissertation (Kaunas): Lithuanian university of health sciences. 2014.
28. Green J, Thorogood N. Qualitative methods for health research. London: SAGE Publ; 2004.
29. Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398–405.
30. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–8.
31. Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–1155.
32. Sandelowski M. The problem of rigor in qualitative research. ANS Adv Nurs Sci. 1986;8:27–37.
33. Bondas T, Hall EOC. Challenges in approaching metasynthesis research. Qual Health Res. 2007;17:113–21.
34. Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105–12.
35. Lyerly AD, Mitchell LM, Armstrong EM, Harris LH, Kukla R, Kuppermann M, Little MO. Risks, values, and decision making surrounding pregnancy. Obstet Gynecol. 2007;109(4):979–84.
36. Holst L, Wright D, Haavik S, Nordeng H. The Use and the User of Herbal Remedies During Pregnancy. J Altern Complement Med. 2009;15(7):787–92.
37. Holst L, Wright D, Nordeng H, Haavik S. Use of herbal preparations during pregnancy: focus group discussion among expectant mothers attending a hospital antenatal clinic in Norwich, UK. Complement Ther Clin Pract. 2009;15(4):225–9.
38. Low Dog T. The use of botanicals during pregnancy and lactation. Altern Ther Health Med. 2009;15(1):54–8.
39. Jayawickrama HS, Amir LS, Pirotta MV. GPs’ decision-making when prescribing medicines for breastfeeding women: content analysis of a survey. BMC Res Notes. 2010;3:82. doi:10.1186/1756-0500-3-82.
40. Pucinskiene L. Market of herbal preparations in Lithuania (master theses). (Kaunas): Kaunas Medical University. 2006.
41. Herbal/Traditional Products in Lithuania (Internet). Euromonitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-lithuania/report.
42. Herbal/Traditional Products in Latvia (Internet). Euromonitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-latvia/report.
43. Herbal/Traditional Products in Estonia (Internet). Eurominitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-estonia/report.
44. Herbal/Traditional Products in Poland (Internet). Euromonitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-poland/report.
45. Herbal/Traditional Products in the Netherlands (Internet). Euromonitor International. 2013. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-the-netherlands/report.
46. Herbal/Traditional Products in Denmark (Internet). Euromonitor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-denmark/report.
47. Herbal/Traditional Products in the United Kingdom (Internet). Euromintor International. 2014. (cited 2014 July 11). http://www.euromonitor.com/herbal-traditional-products-in-the-united-kingdom/report.
48. Echamp EEIG. The Availability of Homeopathic and Anthroposophic Medicinal Products in the EU. Brussels: ECHAMP; 2012.
49. Traulsen JM, Bissell P. Theories of professions and the pharmacist. Int J Pharm Prac. 2004;12:107–14.
50. Birenbaum A. Reprofessionalisation in pharmacy. Sot Sci Med. 1982;16:871–8.
51. Makowsky MJ, Guirguis LM, Hughes CA, Sadowski CA, Yuksel N. Factors influencing pharmacists’ adoption of prescribing: qualitative application of the diffusion of innovations theory. Implement Sci. 2013;8:109.
52. Rogers A, Hassell K, Noyce P, Harris J. Advice-giving in community pharmacy: variations between pharmacies in different locations. Health Place. 1998;4(4):365–73.
53. Royal Pharmaceutical Society of Great Britain. Medicines, ethics and practice. A guide for pharmacists. 37th ed. London: Royal Pharmaceutical Society. 2013.
54. International Pharmaceutical Federation (FIP). FIP reference paper on the effective utilization of pharmacists in improving maternal, newborn and child health (MNCH) (Internet). (Dublin): FIP Council. 2013. (cited 2014 Apr 21). http://www.fip.org/www/uploads/database_file.php?id=343&table_id=.